These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 7308639)

  • 1. [19-norandrostenolone undecylate in the treatment of anemia in patients treated with periodic hemodialysis].
    Docci D; Feliciangeli G; Mosconi G; Vangelista A; Stefoni S
    G Clin Med; 1981 Aug; 62(8):567-75. PubMed ID: 7308639
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anemia in patients treated with periodic hemodialysis. Therapeutic criteria and long-term results].
    Bucciante G; Frizzi V; Bernardi AM; Amadori G
    Minerva Urol; 1978; 30(2):85-95. PubMed ID: 703731
    [No Abstract]   [Full Text] [Related]  

  • 3. [Quinbolone in the therapy of anemia in uremic patients during periodic hemodialytic treatment].
    Amato M; Bigioli F; Beconi D; Martinelli F; Lapini V; Salvadori M
    Clin Ter; 1980 Jul; 94(1):57-65. PubMed ID: 7438723
    [No Abstract]   [Full Text] [Related]  

  • 4. Nandrolone decanoate therapy for patients receiving hemodialysis. A controlled study.
    Williams JS; Stein JH; Ferris TF
    Arch Intern Med; 1974 Aug; 134(2):289-92. PubMed ID: 4602048
    [No Abstract]   [Full Text] [Related]  

  • 5. Controlled study of androgen therapy in anemia of patients on maintenance hemodialysis.
    Hendler ED; Goffinet JA; Ross S; Longnecker RE; Bakovic V
    N Engl J Med; 1974 Nov; 291(20):1046-51. PubMed ID: 4606387
    [No Abstract]   [Full Text] [Related]  

  • 6. Response of uremic patients to nandrolone decanoate.
    Doane BD; Fried W; Schwartz F
    Arch Intern Med; 1975 Jul; 135(7):972-5. PubMed ID: 1156056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen trial in renal anaemia.
    Naik RB; Gibbons AR; Gyde OH; Harris BR; Robinson BH
    Proc Eur Dial Transplant Assoc; 1978; 15():136-43. PubMed ID: 368770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of nandrolone decanoate on the anemia of chronic hemodialysis patients.
    Buchwald D; Argyres S; Easterling RE; Oelshlegel FJ; Brewer GJ; Schoomaker EB; Abbrecht PH; Williams GW; Weller JM
    Nephron; 1977; 18(4):232-8. PubMed ID: 323739
    [No Abstract]   [Full Text] [Related]  

  • 9. [Testosterone in the therapy of anemia in the uremic patient treated by periodic hemodialysis].
    Brancaccio D; Pincella G; Graziani G; Redaelli B
    Minerva Nefrol; 1972; 19(4):269-73. PubMed ID: 4681104
    [No Abstract]   [Full Text] [Related]  

  • 10. [Iron poisoning as a risk in the treatment of nephrogenic anemia].
    Hansen BL; Pedersen FB
    Ugeskr Laeger; 1985 Aug; 147(35):2747-9. PubMed ID: 4071711
    [No Abstract]   [Full Text] [Related]  

  • 11. [Histidine in the treatment of anemia in patients with chronic renal failure treated by hemodialysis].
    Rutkowski B; Góra E; Barlik J; Manitius J; Jakubowski Z
    Pol Tyg Lek; 1987 Aug; 42(34):1031-4. PubMed ID: 3422836
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of anemia in chronic hemodialysis patients.
    Wedeen RP; Lipat GA; Morse BS
    J Med Soc N J; 1975 Mar; 72(3):207-11. PubMed ID: 1055260
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of chronic uremic anemia in patients undergoing periodic extracorporeal dialysis with large doses of anabolic androgens].
    Pentangelo C; Mazza L; Scoppa F
    Rass Int Clin Ter; 1971 Oct; 51(20):1268-76. PubMed ID: 5137470
    [No Abstract]   [Full Text] [Related]  

  • 14. Problems in adaptation to maintenance hemodialysis. A four-year study of 25 patients.
    Reichsman F; Levy NB
    Arch Intern Med; 1972 Dec; 130(6):859-65. PubMed ID: 5082466
    [No Abstract]   [Full Text] [Related]  

  • 15. The effective use of nandrolone decanoate in the management of the anemia of uremia: a prospective study.
    Armitage JO; Leighton M; Ware F
    Nebr Med J; 1976 Jun; 61(6):202-6. PubMed ID: 1272455
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prophylactic and conservative treatment of arteriovenous shunts in chronic kidney disease patients treated with periodic hemodialysis].
    Ancona G
    Chir Patol Sper; 1966; 14(7):246-65. PubMed ID: 5990179
    [No Abstract]   [Full Text] [Related]  

  • 17. [The treatment of chronic hyperazotemic nephropathies with periodic hemodialysis].
    Galanti G
    Minerva Med; 1967 Dec; 58(97):4323-5. PubMed ID: 6082385
    [No Abstract]   [Full Text] [Related]  

  • 18. Nandrolone decanoate therapy for anemia in patients on haemodialysis.
    Balaji HD; Hariharan S; Jacob CK; Kirubakaran MG; Shastry JC
    J Assoc Physicians India; 1988 Nov; 36(11):677-8. PubMed ID: 3074079
    [No Abstract]   [Full Text] [Related]  

  • 19. [Low doses of recombinant erythropoietin in the treatment of renal anemia in patients on chronic hemodialysis and ambulatory peritoneal dialysis].
    Lashutin SV; Nikolaev AIu; Ermolenko VM; Shutov EV; Bezruk VG; Ivashchenko MA
    Ter Arkh; 1999; 71(6):61-3. PubMed ID: 10420460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Our experience with hemodialysis in the treatment of uremia].
    Rapisarda LM; Mangione S; Damiani S
    Minerva Med; 1970 Nov; 61(90):5114-22. PubMed ID: 5488542
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.